Related Experiment Video
Updated: Aug 26, 2025

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
Published on: November 10, 2023
Bronchiectasis in children following kidney transplantation in New Zealand
Jacqueline Everitt1, Anna Mulholland1, Vivian Kim1
1Renal Department, Starship Children's Hospital, Auckland, New Zealand.
Insights
Children undergoing kidney transplants in New Zealand have a significantly higher incidence of bronchiectasis. Early investigation of respiratory symptoms in these pediatric patients is crucial for timely diagnosis and management of this lung condition.
Area of Science:
- Pediatric Nephrology
- Pulmonology
- Transplant Immunology
Background:
- Bronchiectasis is a chronic respiratory condition with notable incidence in New Zealand children.
- International reports indicate a link between bronchiectasis and kidney transplantation.
- Understanding this association in pediatric kidney transplant recipients is critical.
Purpose of the Study:
- To determine the incidence rate of bronchiectasis post-pediatric kidney transplantation.
- To evaluate the impact of bronchiectasis on kidney allograft function.
- To identify potential risk factors for earlier diagnosis.
Main Methods:
- A case-control study design was employed.
- Included children who underwent kidney transplantation in New Zealand between 2001 and 2016.
- Matched cases with controls who did not develop bronchiectasis.
Main Results:
- Eight out of 95 (8.4%) pediatric kidney transplant recipients developed bronchiectasis.
- The incidence rate was 526 per 100,000 pediatric kidney transplant population annually.
- No significant differences in immunosuppression or allograft function were observed between groups.
Conclusions:
- The incidence of bronchiectasis following pediatric kidney transplantation is substantially elevated compared to the general pediatric population.
- Prompt investigation of chronic cough or recurrent lower respiratory tract infections in these children is recommended.
- Maintaining a high index of suspicion for bronchiectasis is advised for post-transplant pediatric care.
Aim:
Bronchiectasis is an acquired chronic respiratory condition with a relatively high incidence in New Zealand children. Bronchiectasis following kidney transplant has been reported internationally. This study aimed to identify the incidence rate of bronchiectasis following paediatric kidney transplantation. Secondary aims were to assess the impact on kidney allograft function and identify risk factors that might prompt earlier diagnosis.
Methods:
Case control study of children who developed bronchiectasis following kidney transplant in New Zealand. All children who were transplanted during the 16-year period from 2001 to 2016 were included. Each identified case was matched with two controls (children who did not develop bronchiectasis and received a kidney transplant within the closest time period to their matched case). Data were collected on baseline demographics, clinical variables, immunosuppression and allograft function.
Results:
Of 95 children who had a kidney transplant during the specified time period, eight (8.4%) developed bronchiectasis at a median of 4 years post-transplant. The mean incidence rate of bronchiectasis was 526 cases per 100 000 paediatric kidney transplant population per year. The majority of children were Māori or Pasifika ethnicity and lived in areas of greater socio-economic deprivation. Immunosuppression burden and allograft function were not significantly different between groups.
Conclusions:
The incidence rate of bronchiectasis following paediatric kidney transplantation is substantially higher than the baseline paediatric incidence rate in New Zealand. A high index of suspicion for bronchiectasis and prompt investigation of children post kidney transplantation with a history of recurrent lower respiratory tract infection or chronic cough are advised.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Kidney Transplant I: Introduction
Kidney Transplant III: Nursing Management

